Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 2270

1.

Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis.

Kasumov T, Li L, Li M, Gulshan K, Kirwan JP, Liu X, Previs S, Willard B, Smith JD, McCullough A.

PLoS One. 2015 May 20;10(5):e0126910. doi: 10.1371/journal.pone.0126910. eCollection 2015.

2.

Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.

Imai N, Suzuki M, Hayashi K, Ishigami M, Hirooka Y, Abe T, Shioi G, Goto H, Fujimoto T.

PLoS One. 2015 May 13;10(5):e0127114. doi: 10.1371/journal.pone.0127114. eCollection 2015.

3.

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.

Lee TH, Matta B, King BD, Hodges MR, Tillmann HL, Patel K.

J Med Virol. 2015 May 11. doi: 10.1002/jmv.24230. [Epub ahead of print]

PMID:
25963774
4.

Inactivation of ANGPTL3 Reduces Hepatic VLDL-triglyceride Secretion.

Wang Y, Gusarova V, Banfi S, Gromada J, Cohen JC, Hobbs HH.

J Lipid Res. 2015 May 7. pii: jlr.M054882. [Epub ahead of print]

5.

Three-dimensional (3D) spheroid cultures improve the metabolic gene expression profiles of HepaRG cells.

Takahashi Y, Hori Y, Yamamoto T, Urashima T, Ohara Y, Tanaka H.

Biosci Rep. 2015 May 7. [Epub ahead of print]

6.

Novel method for reducing plasma cholesterol: a ligand replacement therapy.

Anantharamaiah GM, Goldberg D.

Clin Lipidol. 2015 Jan 1;10(1):83-90.

PMID:
25937835
7.

Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents.

Jin R, Le NA, Cleeton R, Sun X, Cruz Muños J, Otvos J, Vos MB.

Lipids Health Dis. 2015 May 1;14(1):39. doi: 10.1186/s12944-015-0038-x.

8.

Dietary Njavara rice bran oil reduces experimentally induced hypercholesterolaemia by regulating genes involved in lipid metabolism.

Chithra PK, Sindhu G, Shalini V, Parvathy R, Jayalekshmy A, Helen A.

Br J Nutr. 2015 Apr;113(8):1207-19. doi: 10.1017/S0007114515000513. Epub 2015 Mar 30.

PMID:
25823019
9.
10.

The APOB insertion/deletion polymorphism (rs17240441) influences postprandial lipaemia in healthy adults.

Vimaleswaran KS, Minihane AM, Li Y, Gill R, Lovegrove JA, Williams CM, Jackson KG.

Nutr Metab (Lond). 2015 Mar 8;12:7. doi: 10.1186/s12986-015-0002-9. eCollection 2015.

11.

Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia.

Kawashiri MA, Tada H, Hashimoto M, Taniyama M, Nakano T, Nakajima K, Inoue T, Mori M, Nakanishi C, Konno T, Hayashi K, Nohara A, Inazu A, Koizumi J, Ishihara H, Kobayashi J, Hirano T, Mabuchi H, Yamagishi M.

JIMD Rep. 2015 Mar 13. [Epub ahead of print]

PMID:
25763510
12.

Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.

Chhatrala R, Siddiqui MB, Stravitz RT, Driscoll C, Sanyal A, Sargeant C, Luketic V, Sharma A, Sterling R, Matherly S, Puri P, Siddiqui MS.

Liver Transpl. 2015 May;21(5):623-30. doi: 10.1002/lt.24100. Epub 2015 Apr 15.

PMID:
25762084
13.

Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus.

Besseling J, Kastelein JJ, Defesche JC, Hutten BA, Hovingh GK.

JAMA. 2015 Mar 10;313(10):1029-36. doi: 10.1001/jama.2015.1206.

PMID:
25756439
14.

Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation.

Rojas JM, Bruinstroop E, Printz RL, Alijagic-Boers A, Foppen E, Turney MK, George L, Beck-Sickinger AG, Kalsbeek A, Niswender KD.

Mol Metab. 2015 Jan 16;4(3):210-21. doi: 10.1016/j.molmet.2015.01.004. eCollection 2015 Mar.

15.

Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine model.

Silva M, da Costa Guerra JF, Sampaio AF, de Lima WG, Silva ME, Pedrosa ML.

Biomed Res Int. 2015;2015:272617. doi: 10.1155/2015/272617. Epub 2015 Jan 18.

16.

Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome.

Arca M.

Atheroscler Suppl. 2015 Feb;17:12-6. doi: 10.1016/S1567-5688(15)50004-4.

PMID:
25659871
17.

Phospholipid transfer protein plays a major role in the initiation of apolipoprotein B-containing lipoprotein assembly in mouse primary hepatocytes.

Manchekar M, Liu Y, Sun Z, Richardson PE, Dashti N.

J Biol Chem. 2015 Mar 27;290(13):8196-205. doi: 10.1074/jbc.M114.602748. Epub 2015 Jan 31.

PMID:
25638820
18.

Zebrafish as a model for apolipoprotein biology: comprehensive expression analysis and a role for ApoA-IV in regulating food intake.

Otis JP, Zeituni EM, Thierer JH, Anderson JL, Brown AC, Boehm ED, Cerchione DM, Ceasrine AM, Avraham-Davidi I, Tempelhof H, Yaniv K, Farber SA.

Dis Model Mech. 2015 Mar;8(3):295-309. doi: 10.1242/dmm.018754. Epub 2015 Jan 29.

19.

Clathrin mediates infectious hepatitis C virus particle egress.

Benedicto I, Gondar V, Molina-Jiménez F, García-Buey L, López-Cabrera M, Gastaminza P, Majano PL.

J Virol. 2015 Apr;89(8):4180-90. doi: 10.1128/JVI.03620-14. Epub 2015 Jan 28.

PMID:
25631092
20.

Apolipoprotein A-V deficiency enhances chylomicron production in lymph fistula mice.

Zhang LS, Xu M, Yang Q, Ryan RO, Howles P, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2015 Apr 1;308(7):G634-42. doi: 10.1152/ajpgi.00339.2014. Epub 2015 Jan 23.

PMID:
25617349
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk